161 related articles for article (PubMed ID: 772175)
1. Bromocriptine treatment in Parkinson's disease.
Parkes JD; Marsden CD; Donaldson I; Galea-Debono A; Walters J; Kennedy G; Asselman P
J Neurol Neurosurg Psychiatry; 1976 Feb; 39(2):184-93. PubMed ID: 772175
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Parkes JD; Debono AG; Marsden CD
J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Jellinger K
J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Godwin-Austen RB; Smith NJ
J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Marsden CD
Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
[TBL] [Abstract][Full Text] [Related]
6. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
7. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Parkinson's disease with dopamine agonists: a review.
Lieberman A; Neophytides A; Kupersmith M; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
Am J Med Sci; 1979; 278(1):65-76. PubMed ID: 39452
[TBL] [Abstract][Full Text] [Related]
9. Pergolide in late-stage Parkinson disease.
Lang AE; Quinn N; Brincat S; Marsden CD; Parkes JD
Ann Neurol; 1982 Sep; 12(3):243-7. PubMed ID: 6753730
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Parkinson's disease with lergotrile mesylate.
Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M
JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
15. The antiparkinsonian efficacy of bromocriptine.
Lieberman A; Zolfaghari M; Boal D; Hassouri H; Vogel B; Battista A; Fuxe K; Goldstein M
Neurology; 1976 May; 26(5):405-9. PubMed ID: 817221
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
17. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Biesemeyer H; Ludin HP; Ringwald E
J Neurol; 1983; 230(1):19-23. PubMed ID: 6194269
[TBL] [Abstract][Full Text] [Related]
19. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Montastruc JL; Rascol O; Rascol A
Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
